{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:10:44Z","timestamp":1759407044125,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.vaccine.2023.10.009","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T13:41:19Z","timestamp":1696945279000},"page":"6824-6833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antibodies elicited by Plasmodium falciparum circumsporozoite proteins lacking sequentially deleted C-terminal amino acids reveal mouse strain and epitopes specific differences"],"prefix":"10.1016","volume":"41","author":[{"given":"Clifford T.H.","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8780-1350","authenticated-orcid":false,"given":"Yi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fidel","family":"Zavala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayk","family":"Simonyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin N.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0358-4924","authenticated-orcid":false,"given":"Nirbhay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"unstructured":"Organization WH. World malaria report 2022. 2022.","key":"10.1016\/j.vaccine.2023.10.009_b0005"},{"key":"10.1016\/j.vaccine.2023.10.009_b0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS, S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","author":"Sctp","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.10.009_b0015","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S1473-3099(15)00239-X","article-title":"Immunogenicity of the RTS, S\/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial","volume":"15","author":"White","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.10.009_b0020","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1586\/erv.12.92","article-title":"Pre-erythrocytic malaria vaccines: identifying the targets","volume":"11","author":"Duffy","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2023.10.009_b0025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mib.2016.04.006","article-title":"Malaria vaccines and human immune responses","volume":"32","author":"Long","year":"2016","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.vaccine.2023.10.009_b0030","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.6204383","article-title":"Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum","volume":"225","author":"Dame","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2023.10.009_b0035","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201313","article-title":"How to induce protective humoral immunity against Plasmodium falciparum circumsporozoite protein","volume":"219","author":"Wahl","year":"2022","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2023.10.009_b0040","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1146\/annurev.iy.11.040193.003351","article-title":"T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages","volume":"11","author":"Nardin","year":"1993","journal-title":"Annu Rev Immunol"},{"issue":"142","key":"10.1016\/j.vaccine.2023.10.009_b0045","first-page":"4000","article-title":"Human T cell recognition of polymorphic epitopes from malaria circumsporozoite protein","volume":"1989","author":"De Groot","year":"1950","journal-title":"J Immunolo (Baltimore, Md: 1950)"},{"key":"10.1016\/j.vaccine.2023.10.009_b0050","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.2434994","article-title":"Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein","volume":"235","author":"Good","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2023.10.009_b0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4161\/hv.6.1.9677","article-title":"From the circumsporozoite protein to the RTS, S\/AS candidate vaccine","volume":"6","author":"Cohen","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2023.10.009_b0060","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.coi.2018.04.023","article-title":"From human antibody structure and function towards the design of a novel Plasmodium falciparum circumsporozoite protein malaria vaccine","volume":"53","author":"Wardemann","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2023.10.009_b0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-020-00274-4","article-title":"An epitope-based malaria vaccine targeting the junctional region of circumsporozoite protein","author":"Jel\u00ednkov\u00e1","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2023.10.009_b0070","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nm.4512","article-title":"A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite","volume":"24","author":"Kisalu","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2023.10.009_b0075","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nm.4513","article-title":"A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein","volume":"24","author":"Tan","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2023.10.009_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.08.014","article-title":"A potent anti-malarial human monoclonal antibody targets circumsporozoite protein minor repeats and neutralizes sporozoites in the liver","volume":"53","author":"Wang","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2023.10.009_b0085","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.vaccine.2008.09.097","article-title":"The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity","volume":"27","author":"Bongfen","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.10.009_b0090","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/infdis\/jiv154","article-title":"Proteolytic cleavage of the plasmodium falciparum circumsporozoite protein is a target of protective antibodies","volume":"212","author":"Espinosa","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.10.009_b0095","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1128\/IAI.02676-14","article-title":"Reversible conformational change in the plasmodium falciparum circumsporozoite protein masks its adhesion domains","volume":"83","author":"Herrera","year":"2015","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2023.10.009_b0100","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200061","article-title":"A high-affinity antibody against the CSP N-terminal domain lacks Plasmodium falciparum inhibitory activity","volume":"217","author":"Thai","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2023.10.009_b0105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.20170869","article-title":"Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection","volume":"215","author":"Scally","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2023.10.009_b0110","doi-asserted-by":"crossref","first-page":"e1010409","DOI":"10.1371\/journal.ppat.1010409","article-title":"A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum","volume":"18","author":"Beutler","year":"2022","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2023.10.009_b0115","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.vaccine.2020.12.055","article-title":"Breadth of humoral immune responses to the C-terminus of the circumsporozoite protein is associated with protective efficacy induced by the RTS, S malaria vaccine","volume":"39","author":"Chaudhury","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.10.009_b0120","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1038\/s41467-019-10195-z","article-title":"Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS, S\/AS01E malaria vaccine efficacy","volume":"10","author":"Doba\u00f1o","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2023.10.009_b0125","doi-asserted-by":"crossref","first-page":"e0072820","DOI":"10.1128\/IAI.00728-20","article-title":"Strategic variants of CSP delivered as SynDNA vaccines demonstrate heterogeneity of immunogenicity and protection from plasmodium infection in a murine model","volume":"89","author":"Reeder","year":"2021","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2023.10.009_b0130","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0020-7519(01)00184-9","article-title":"DNA-based vaccines against malaria: status and promise of the multi-stage malaria DNA vaccine operation","volume":"31","author":"Doolan","year":"2001","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2023.10.009_b0135","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1521-4141(200103)31:3<692::AID-IMMU692>3.0.CO;2-Y","article-title":"Removal of the circumsporozoite protein (CSP) glycosylphosphatidylinositol signal sequence from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improvesprotection against malaria infection","volume":"31","author":"Scheiblhofer","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2023.10.009_b0140","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3390\/vaccines10071134","article-title":"Effective functional immunogenicity of a DNA vaccine combination delivered via in vivo electroporation targeting malaria infection and transmission","volume":"10","author":"Cao","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2023.10.009_b0145","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/S0264-410X(99)00407-7","article-title":"Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers","volume":"18","author":"Le","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.10.009_b0150","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1186\/s12936-019-3055-9","article-title":"Optimization of an in vivo model to study immunity to Plasmodium falciparum pre-erythrocytic stages","volume":"18","author":"Flores-Garcia","year":"2019","journal-title":"Malar J"},{"key":"10.1016\/j.vaccine.2023.10.009_b0155","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1002\/eji.1830211217","article-title":"Immunogenicity of multiple antigen peptides (MAP) containing T and B cell epitopes of the repeat region of the P. falciparum circumsporozoite protein","volume":"21","author":"Munesinghe","year":"1991","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2023.10.009_b0160","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.4049\/jimmunol.165.3.1453","article-title":"The complexity of protective immunity against liver-stage malaria1 2","volume":"165","author":"Doolan","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2023.10.009_b0165","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/330664a0","article-title":"\u03b3 Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites","volume":"330","author":"Schofield","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2023.10.009_b0170","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1073\/pnas.85.2.573","article-title":"CD8+ T cells (cytotoxic\/suppressors) are required for protection in mice immunized with malaria sporozoites","volume":"85","author":"Weiss","year":"1988","journal-title":"Proc Natl Acad Sci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23011799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23011799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:30:21Z","timestamp":1759404621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23011799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":34,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0264410X23011799"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.10.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibodies elicited by Plasmodium falciparum circumsporozoite proteins lacking sequentially deleted C-terminal amino acids reveal mouse strain and epitopes specific differences","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}